Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Median Technologies    ALMDT   FR0011049824

SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2012 | 07:35am CEST

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

Regulatory News:

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

For more information on MEDIAN, please visit: www.mediantechnologies.com

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
[email protected]
or
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
[email protected]
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIAN TECHNOLOGIES
06/28 MEDIAN TECHNOLOGIES : Partners to Deliver Image Management Services
06/22 MEDIAN TECHNOLOGIES : and Medidata Partner to Deliver Differentiated Image Manag..
05/31 MEDIAN TECHNOLOGIES : to Attend the 2017 ASCO Annual Meeting, June 2-6, 2017, Mc..
04/25 MEDIAN TECHNO : Technologies is awarded the 2017 Tech 40 Label and joins EnterNe..
04/25 MEDIAN TECHNOLOGIES : is Awarded the 2017 Tech 40 Label and Joins EnterNext Tech..
04/12 MEDIAN TECHNOLOGIES : Publication of the Annual Report for Financial Year 2016
04/12 MEDIAN TECHNOLOGIES : Reports Full Year 2016 Financial Results
04/06 MEDIAN TECHNOLOGIES : and inVentiv Health Announce Strategic Alliance to Provide..
02/28 MEDIAN TECHNOLOGIES : to Present at Cowen and Company 37th Annual Health Care Co..
02/14 MEDIAN TECHNOLOGIES : to Attend the Annual Meeting of the Asian Pacific Associat..
More news
Sector news : Software - NEC
10:48a European shares steady as Fed move boosts bank
04:36a Meal-kit maker Blue Apron goes public, demand underwhelms as Amazon looms
06/28DJGlobal Firms Work to Contain Fallout From Cyberattack -- 6th Update
06/28DJGlobal Firms Work to Contain Fallout From Cyberattack -- 5th Update
06/28DJGlobal Firms Work to Contain Fallout From Cyberattack -- 4th Update
More sector news : Software - NEC
Advertisement
Chart MEDIAN TECHNOLOGIES
Duration : Period :
Median Technologies Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Full-screen chart
Technical analysis trends MEDIAN TECHNOLOGIES
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Managers
NameTitle
Fredrik Bjjorn Brag Chairman, CEO & Head-Investor Relations
Jeanne Hecht Director & Chief Operating Officer
Bernard Reymann Chief Financial Officer
Arnaud Butzbach Chief Technology Officer & VP-Operations
Gerard Milhiet Director & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIAN TECHNOLOGIES12.36%163
MICROSOFT CORPORATION12.33%538 892
RED HAT INC37.73%17 186
HEXAGON24.82%16 314
CITRIX SYSTEMS14.23%12 278
SYNOPSYS, INC.26.16%11 162
More Results